Skanska wins contract to build new pharmaceutical manufacturing facility in US

WCN Editorial Team 23 Dec 2021 NORTH AMERICA BUILDINGS

US-based pharmaceutical firm Continuus Pharmaceuticals has awarded a contract to construction firm Skanska to construct a new pharmaceutical manufacturing facility in Woburn, Massachusetts, US.

The contract, worth $125m, will be included in the company’s US order bookings for the fourth quarter of this year.

The scope of work under the contract involves renovation and construction of a new 50,000ft2 cGMP manufacturing facility in an existing shell space.

Dry active pharmaceutical ingredients (API) as well as finished drug products (DP) will be produced at the new facility in both tablet and sterile injectable forms.

The new pharmaceutical manufacturing plant will produce three critical care medicines as well as one additional key drug along with flexibility for future growth.

The company’s work under the contract also includes construction of a new third-floor penthouse, utility structure and extensive supporting utility equipment.

A new dunnage system will be installed over the existing roof to support a modular air handling unit penthouse.

Skanska stated that the existing roof will be raised to enable additional equipment support areas and API manufacturing heights.

Construction work on the project is scheduled to be completed in the second quarter of next year.

Recently, the construction company announced €22m investment in a residential development project in Helsinki, Finland.

Located in the new area of Kruunuvuori, the development comprises 61 apartments.

Solar panels will be installed on the roof of the development to generate electricity, which will be used by the property.

Construction work of the project is anticipated to be completed in the fourth quarter of 2023.

---------------------------------------------------------------------------------------------------------------------

The new pharmaceutical manufacturing plant will produce three critical care medicines and one additional key drug. Credit: Arek Socha from Pixabay.

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US
PRIVACY POLICY

STAY IN TOUCH!

LATEST TWEETS

World Construction Network | www.worldconstructionnetwork.com is a product of GlobalData. Copyright © 2022 GlobalData. All rights reserved.